INVESTIGATION OF URSODEOXYCHOLIC ACID EFFECTS ON SIROLIMUS TREATED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
Authors:
- Esra Arisu NaghaviENEsra Arisu Naghavi
- Bakiye Goker BagcaBBBakiye Goker Bagca
- Senem Tekeli̇STSenem Tekeli̇
- Gürkan Yi̇ğİtTürkGYGürkan Yi̇ğİtTürk
- Burak GökçeBGBurak Gökçe
- Canberk TomrukCTCanberk Tomruk
- Türker ÇavuşoğluTÇTürker Çavuşoğlu
- Çığır AvciÇAÇığır Avci
- Cumhur GündüzCGCumhur Gündüz
- Yiğit UYANIKGİLYiğit UYANIKGİL
Open Access
- 30 September 2022
- journal article
- research article
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 29 (3) , 324-334
Abstract
Objective The usage of mesenchymal stem cells (MSC) with immunosuppressive drugs after organ transplantation is becoming remarkable in clinical applications. However, the drugs negatively affect MSCs. Ursodeoxycholic acid (UDCA), which is an antioxidant molecule, may reverse these effects. The study aims that to determine the effects of sirolimus and UDCA on human adipose tissue-derived MSCs (ADMSCs) individually and in combination. Material and Method The cytotoxicity of the agents was evaluated by WST-1 test in time and dose-dependent manner. The combinational effects were determined using isobologram analysis. Muse cell analyzer was used for the evaluation of apoptosis and cell cycle. Oxidative stress markers were measured by biochemical methods. Results IC50 dose of sirolimus was determined as 18.58μM in the 48th hour. Because no cytotoxic effect was observed at the studied doses of UDCA, the apoptosis, cell cycle, and oxidative stress indicator analyses were continued with a safe dose of 100 μM. Sirolimus promoted apoptosis and inhibited cell proliferation. It was determined that UDCA reduced the apoptotic and anti-proliferative effects of sirolimus on ADMSCs with its anti-oxidant property. Conclusion The UDCA treatment in combination with immunosuppressive therapy after organ and tissue transplantation may have positive effects on ADMSCs.Keywords
Funding Information
- Ege University Research Foundation (2015/TIP/010)
This publication has 34 references indexed in Scilit:
- Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation ModeInternational Journal of Molecular Sciences, 2012
- Bile-acid-induced cell injury and protectionWorld Journal of Gastroenterology, 2009
- Ursodeoxycholic acid: Mechanism of action and novel clinical applicationsHepatology Research, 2007
- p53 Is a Key Molecular Target of Ursodeoxycholic Acid in Regulating ApoptosisJournal of Biological Chemistry, 2007
- Upstream and downstream of mTORGenes & Development, 2004
- Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantationBone Marrow Transplantation, 2004
- Mesenchymal stem cells: clinical applications and biological characterizationThe International Journal of Biochemistry & Cell Biology, 2004
- Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stressHepatology, 2004
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.Journal of Clinical Investigation, 1998
- Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and childrenPharmacology & Therapeutics, 1995